Denmark is not going to use the Johnson & Johnson vaccine, the Danish Well being Authority introduced on Monday, saying in an announcement that the nation may make ample progress utilizing different vaccines and didn’t must run the danger of a uncommon, harmful blood clotting situation that could be linked to the Johnson & Johnson vaccine.
The nation has halted administering the AstraZeneca vaccine for comparable causes, after two individuals died of blood clots after being on condition that vaccine.
Denmark had been planning to make use of the Johnson & Johnson single-dose vaccine earlier than studies emerged a couple of potential hyperlink to the clotting situation, which appears to primarily have an effect on youthful ladies. Dropping the vaccine from its plans will set again the nation’s timetable for vaccinating adults below 40 by a couple of month, Danish officers mentioned.
The US briefly suspended utilizing the Johnson & Johnson vaccine, however the Meals and Drug Administration introduced on Friday that it might be made obtainable once more, with a warning concerning the potential clotting threat added to its label.
The European Medicines Company, the regulatory physique for the European Union, has additionally endorsed use of the Johnson & Johnson vaccine with an added warning.
The Danish Well being Authority, nonetheless, mentioned it had independently investigated the vaccine and determined towards utilizing it.
“Taking the current state of affairs in Denmark into consideration, what we’re presently shedding in our effort to stop extreme sickness from Covid-19 can not outweigh the danger of inflicting potential negative effects within the type of extreme blood clots in these we vaccinate,” the authority mentioned in an announcement.
“One must also keep in mind that, going ahead, we are going to before everything be vaccinating youthful and wholesome individuals,” Helene Probst, the deputy director common of the authority, mentioned within the assertion.
Christina Anderson contributed reporting.